Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats

Kidney International

Volumn 68, Issue 2, 2005, Pages 515-528

  Ito, Keiichi ^b   Chen, Jie ^b   Seshan, Surya V ^b   J Khodadadian, Jonathan ^b   Gallagher, Rachel ^b   Chaar, Maher El ^b   Vaughan, Edarracott ^b   Poppas, Dix P ^b   Felsen, Diane ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

L arginine; Nitric oxide; Renal function; S100A4; Tubular apoptosis; Unilateral ureteral obstruction

Indexed keywords

4 AMINOHIPPURIC ACID; ARGININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INULIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; CYCLIC GMP; CYCLINE; ENZYME INHIBITOR; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; NOS2 PROTEIN, RAT; NOS3 PROTEIN, RAT; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE EXACERBATION; ENZYME ASSAY; FIBROBLAST; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE NECROSIS; MACROPHAGE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPECIES COMPARISON; TREATMENT OUTCOME; URETER OBSTRUCTION; ANIMAL; DRUG ANTAGONISM; FIBROSIS; KIDNEY; MACROPHAGE; METABOLISM; NICK END LABELING; ORGAN SIZE; PATHOLOGY; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; ARGININE; CYCLIC GMP; DIETARY SUPPLEMENTS; ENZYME INHIBITORS; FIBROBLASTS; FIBROSIS; GLOMERULAR FILTRATION RATE; IN SITU NICK-END LABELING; KIDNEY; MACROPHAGES; MALE; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; ORGAN SIZE; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; URETERAL OBSTRUCTION;

EID: 26944451356     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00429.x     Document Type: Article

References (42)

1. GULMI FA, FELSEN D, VAUGHAN ED, JR.: Pathophysiology of urinary tract obstruction, in Campbell's Urology, 8th ed., edited byWalsh P, Retik A, Vaughan EJ, Wein A, Philadelphia, WB Saunders, 2002
2. BANDER SJ, BUERKERT JE, MARTIN D, et al: Long-term effects of 24-hr unilateral ureteral obstruction on renal function in the rat. Kidney Int 28:614-620, 1985
3. FLAM T, VENOT A, BARIETY J: Reversible hydronephrosis in the rat: A new surgical technique assessed by radioisotopic measurements. J Urol 131:796-798, 1984
4. MCDOUGAL WS: Pharmacologic preservation of renal mass and function in obstructive uropathy. J Urol 128:418-421, 1982
5. VAUGHAN ED, JR., SWEET RE, GILLENWATER JY: Unilateral ureteral occlusion: Pattern of nephron repair and compensatory response. J Urol 109:979-982, 1973
6. CHEVALIER RL, KIM A, THORNHILL BA, et al: Recovery following relief of unilateral ureteral obstruction in the neonatal rat. Kidney Int 55:793-807, 1999
7. CHEVALIER RL, THORNHILL BA, CHANG AY: Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood. Kidney Int 58:1987-1995, 2000
8. CHAN W, KRIEG RJ, JR., WARD K, et al: Progression after release of obstructive nephropathy. Ped Nephrol 16:238-244, 2001
9. HEGARTY NJ, YOUNG LS, KIRWAN N, et al: Nitric oxide in unilateral ureteral obstruction: Effect on regional renal blood flow. Kidney Int 59:1059-1065, 2001
10. FELSEN D, SCHULSINGER DA, GROSS SS, et al: Renal hemodynamic and ureteral pressure changes in response to ureteral obstruction: The role of nitric oxide. J Urol 169:373-376, 2003
11. CHEN CF, YEH SU, CHIEN CT, et al: Renal response during acute unilateral ureteral obstruction in rats. Neurourol Urodyn 20:125-137, 2001
12. ITO K, CHEN J, KHODADADIAN JJ, et al: Liposome-mediated transfer of nitric oxide synthase gene improves renal function in ureteral obstruction in rats. Kidney Int 66:1365-1375, 2004
13. MORRISSEY J, ISHIDOYA S, MCCRACKEN R, et al: Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy. J Am Soc Nephrol 7:2202-2212, 1996.
14. HOCHBERG DA, JOHNSON CW, CHEN J, et al: Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 80:1721-1728, 2000.
15. MIYAJIMA A, CHEN J, KIRMAN I, et al: Interaction of nitric oxide and transforming growth factor-betal induced by angiotensin II and mechanical stretch in rat renal tubular epithelial cells. J Urol 164:1729-1734, 2000
16. ITO K, CHEN J, VAUGHAN ED, JR., et al: Dietary L-arginine supplementation improves the glomerular filtration rate and renal blood flow after 24 hours of unilateral ureteral obstruction in rats. J Urol 171:926-930, 2004
17. ANDOH TF, GARDNER MP, BENNETT WM: Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 64:1236-1240, 1997
18. PETERS H, BORDER WA, NOBLE NA: Tandem antifibrotic actions of L-arginine supplementation and low protein diet during the repair phase of experimental glomerulonephritis. Kidney Int 57:992-1001, 2000
19. ITO K, CHEN J, EL CHAAR M, et al: Renal damage progresses despite improvement of renal function after relief of unilateral ureteral obstruction (UUO) in adult rats. Am J Physiol Renal 287:F1283-F1293, 2004
20. MIYAJIMA A, CHEN J, LAWRENCE C, et al: Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int 58:2301-2313, 2000
21. WRIGHT EJ, MCCAFFREY TA, ROBERTSON AP, et al: Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta. Lab Invest 74:528-537, 1996
22. BARRACLOUGH R: Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1448:190-199, 1998
23. STRUTZ F, OKADA H, LO C, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
24. BOHLE A, MACKENSEN-HAEN S, VON GISE H: Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: A morphometric contribution. Am J Nephrol 7:421-433, 1987
25. SCHAINUCK LI, STRIKER GE, CUTLER R, et al: Structural-functional correlations in renal disease. II. The correlations. Hum Pathol 1:631-641, 1970
26. HEGARTY NJ, WATSON RW, YOUNG LS, et al: Cytoprotective effects of nitrates in a cellular model of hydronephrosis. Kidney Int 62:70-77, 2002
27. DIMMELER S, ZEIHER AM: Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide. Nitric Oxide 1:275-281, 1997
28. POWER RE, DOYLE BI, HIGGINS D, et al: Mechanical deformation induced apoptosis in human proximal renal tubular epithelial cells is caspase dependent. J Urol 171:457-461, 2004
29. REYES A, PORRAS B, CHASALOW FI, et al: L-arginine decreases the infiltration of the kidney by macrophages in obstructive nephropathy and puromycin-induced nephrosis. Kidney Int 45:1346-1354, 1994
30. TAYLOR EL, MEGSON IL, HASLETT C, et al: Nitric oxide: A key regulator of myeloid inflammatory cell apoptosis. Cell Death Differ 10:418-430, 2003
31. FRANK S, KAMPFER H, WETZLER C, et al: Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: A regulatory role for nitric oxide in keratinocyte-derived RANTES expression. Biochem J 347:265-273, 2000
32. HABERSTROH U, STILO K, POCOCK J, et al: L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli. J Am Soc Nephrol 9:203-210, 1998
33. KALLURI R, NEILSON EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784, 2003
34. STAHL PJ, FELSEN D: Transforming growth factor-beta, basement membrane, and epithelial-mesenchymal transdifferentiation: Implications for fibrosis in kidney disease. Am J Path 159:1187-1192, 2001
35. VERNET D, FERRINI MG, VALENTE EG, et al: Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model. Nitric Oxide 7:262-276, 2002
36. DIAMOND JR: Macrophages and progressive renal disease in experimental hydronephrosis. Am J Kidney Dis 26:133-140, 1995
37. BOFFA JJ, LU Y, PLACIER S, et al: Regression of renal vascular and glomerular fibrosis: Role of angiotensin II receptor antagonism and matrix metalloproteinases. J Am Soc Nephrol 14:1132-1144, 2003
38. TOMITA H, EGASHIRA K, OHARA Y, et al: Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension 32:273-279, 1998
39. MIYAJIMA A, CHEN J, POPPAS DP, et al: Role of nitric oxide in renal tubular apoptosis of unilateral ureteral obstruction. Kidney Int 59:1290-1303, 2001
40. MIYAJIMA A, ASANO T, YOSHIMURA I, et al: Tranilast ameliorates renal tubular damage in unilateral ureteral obstruction. J Urol 165:1714-1718, 2001
41. MIYAJIMA A, ITO K, ASANO T, et al: Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? J Urol 166:1124-1129, 2001
42. MORRISSEY J, HRUSKA K, GUO G, et al: Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J Am Soc Nephrol 13(Suppl 1):S14-21, 2002